B Leeneman
Impact in
-
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Skin Protection and Aging
Papers in
- Oncology 13
- Cutaneous Melanoma Detection and Management 11
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
-
- Health Systems, Economic Evaluations, Quality of Life 9
- Co-authors
- M Franken (10 shared papers)Carin A. Uyl‐de Groot (11 shared papers)John B.A.G. Haanen (6 shared papers)Michel W.J.M. Wouters (7 shared papers)Hedwig M. Blommestein (7 shared papers)Pieter van Baal (3 shared papers)Alexander C. J. van Akkooi (3 shared papers)Jacobus J. M. van der Hoeven (2 shared papers)
- Journals
- European Journal of Cancer (5 papers)Value in Health (5 papers)Cancers (1 paper)Melanoma Research (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
B Leeneman
14 papers receiving 155 citations
Peers
Comparison fields: 5 of 54
- Oncology 110
- Dermatology 20
- Immunology 19
- Cancer Research 12
- Economics and Econometrics 21
Countries citing papers authored by B Leeneman
This map shows the geographic impact of B Leeneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Leeneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Leeneman more than expected).
Fields of papers citing papers by B Leeneman
This network shows the impact of papers produced by B Leeneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Leeneman. The network helps show where B Leeneman may publish in the future.
Co-authors
The 25 scholars most cited alongside B Leeneman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 31 | |
| 2 | 2016 | 31 | |
| 3 | 2021 | 27 | |
| 4 | 2021 | 21 | |
| 5 | 2019 | 21 | |
| 6 | 2020 | 12 | |
| 7 | 2015 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2015 | 2 | |
| 10 | 2018 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2024 | 0 |
About B Leeneman
B Leeneman is a scholar working on Oncology, Economics and Econometrics, Molecular Biology, Dermatology and Computational Theory and Mathematics, having authored 16 papers that have together received 158 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (11 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Melanoma and MAPK Pathways (3 papers), CAR-T cell therapy research (3 papers), Computational Drug Discovery Methods (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Oncology (110 citations), Dermatology (20 citations), Immunology (19 citations), Cancer Research (12 citations) and Economics and Econometrics (21 citations). B Leeneman has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include M Franken, Carin A. Uyl‐de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Hedwig M. Blommestein, Pieter van Baal, Alexander C. J. van Akkooi, Jacobus J. M. van der Hoeven, Hans M. Westgeest and K. Schreuder. Their work appears in journals such as European Journal of Cancer, Value in Health, Cancers, Melanoma Research and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.